Table 1.
Baseline Characteristics (N = 124)
| Age, y | 78.9 ± 7.8 |
| Female | 36 (29.0) |
| CKD (eGFR <60 mL/min/1.73 m2) | 35 (28.2) |
| Diabetes | 42 (33.9) |
| Hypertension | 103 (83.1) |
| BMI, kg/m2 | 29.1 ± 5.4 |
| Smoking | 50 (40.3) |
| Former | 41 (82.0) |
| Current | 9 (18.0) |
| Prior stroke/TIA | 19 (15.3) |
| Peripheral arterial disease | 19 (15.3) |
| Coronary artery disease | 76 (61.3) |
| Atrial fibrillation | 38 (30.7) |
| Prior PCI | 39 (31.5) |
| Prior CABG | 30 (24.2) |
| Prior AVR | 8 (6.5) |
| STS PROM | 2.40 (1.40-4.22) |
| NYHA functional class >II | 75 (60.5) |
| CCS class >II | 32 (28.8) |
| Preexisting PPM or ICD | 40 (32.3) |
| Complete RBBB | 3/34 (8.8) |
| Complete LBBB | 4/34 (11.8) |
| High-grade AVB (second-degree type II and above) | 5/12 (41.7) |
| Albumin, g/L (n = 25) | 43.6 ± 3.7 |
| Pre-TAVR EF, % | 58.0 (55.0-60.0) |
| Bicuspid valve | 10 (8.1) |
| Mean AV gradient | 42.0 (33.0-51.0) |
| AV gradient (n = 77) | 0.40 ± 0.12 |
| AR > moderate | 5/75 (6.7) |
Values are mean ± SD, n (%), median (IQR), or n/N (%).
AR = aortic regurgitation; AV = aortic valve; AVB = atrioventricular block; AVR = aortic valve replacement; BMI = body mass index; CABG = coronary artery bypass grafting; CCS = Canadian Cardiovascular Society; CKD = chronic kidney disease; EF = ejection fraction; eGFR = estimated glomerular filtration rate; ICD = implantable cardioverter-defibrillator; LBBB = left bundle branch block; NYHA = New York Heart Association; PCI = percutaneous coronary intervention; PPM = permanent pacemaker; RBBB = right bundle branch block; STS PROM = Society of Thoracic Surgeons Predicted Risk of Mortality; TAVR = transcatheter aortic valve replacement; TIA = transient ischemic attack.